TAG:
lab tests
Palmetto Execs Explain Molecular Test Policies
By Joseph Burns | From the Volume XVIII No. 16 – November 28, 2011 Issue
CEO SUMMARY: To create more transparency in the process clinical labs use to submit claims for genetic tests, molecular diagnostic tests, and for laboratory-developed tests (LDT), the nation’s largest Medicare Administrative Contractor (MAC) has proposed two new local coverage determina…
Medicare Carrier Plans to Reject Molecular Claims
By Robert Michel | From the Volume XVIII No. 15 – November 7, 2011 Issue
CEO SUMMARY: In September, Palmetto, a Medicare carrier serving California and seven other states, made public two draft local coverage determinations (LCDs) that revamp its coverage guidelines for molecular diagnostic tests (MDT) and laboratory-developed tests (LDT). All labs su…
Clin Lab Partners’ Strategy Is to Leverage Lab Data
By Robert Michel | From the Volume XVIII No. 15 – November 7, 2011 Issue
CEO SUMMARY: At Clinical Laboratory Partners, the strategy is to create and deliver a growing suite of enhanced lab information services to client physicians and payers in the Connecticut market. It wants to differentiate itself from competing lab companies by packaging lab test …
At Kaiser Permanente, Real-Time Lab Results Are a Hit with Patients
By Robert Michel | From the Volume XVIII No. 15 – November 7, 2011 Issue
CEO SUMMARY: Should patients be allowed to see their own lab test results when they are available to their physicians? Kaiser Permanente believes so. Since 2005, Kaiser Permanente has given members real-time access to most laboratory test results in their personal health record (PHR) on w…
In Massachusetts, AG Targets Drug Testing Labs
By Robert Michel | From the Volume XVIII No. 14 – October 17, 2011 Issue
CEO SUMMARY: Since taking office in 2007, Massachusetts Attorney General Martha Coakley has aggressively pursued civil charges against drug testing labs. Last month, Coakley announced a criminal arrest in one ongoing investigation after a grand jury indicted a physician in a kick…
LabCorp Inks Agreement In Medi-Cal Pricing Case
By Robert Michel | From the Volume XVIII No. 13 – September 26, 2011 Issue
CEO SUMMARY: In its “Settlement Agreement and Release” with the California Attorney General (AG), Laboratory Corporation of America has negotiated terms that essentially match the agreement that exists between Quest Diagnostics Incorporated and the California AG. These settle…
National Group Names Riedel “Whistleblower of the Year”
By Robert Michel | From the Volume XVIII No. 13 – September 26, 2011 Issue
WHISTLEBLOWING HAS ITS REWARDS. During 2011, one laboratory whistleblower not only harvested tens of millions of dollars in settlement awards, but he was recently honored by a national group for these same efforts. Chris Riedel, President of Hunter Laboratories, Inc., in Campbell, C…
POC Testing Plays Role In Penna. Patient’s Death
By Robert Michel | From the Volume XVIII No. 13 – September 26, 2011 Issue
CEO SUMMARY: In the report by the Pennsylvania Department of Health on the death of a patient at Lehigh Valley Hospital, it was noted that the clinical staff failed to notice discrepancies between results from point-of-care (POC) tests at the bedside and lab test results from blo…
Using Accurate Data to Grow Lab Outreach
By Robert Michel | From the Volume XVIII No. 13 – September 26, 2011 Issue
CEO SUMMARY: In recent years, the laboratory outreach program at the Robert Wood Johnson University Hospital in New Brunswick, New Jersey, has achieved impressive rates of growth in specimen volume and net revenue. One reason for this success is that the lab outreach program moni…
Rhode Island Lab Educates Consumers about Lab Prices
By Robert Michel | From the Volume XVIII No. 12 – September 6, 2011 Issue
TWIN TRENDS NOW CREATE an opportunity for clinical labs and pathology groups to build market share. But tapping these new buyers of laboratory tests will require labs to communicate more effectively with consumers. One trend is the growth in enrollment in health plans that require higher deductibles…
CURRENT ISSUE

Volume XXXII, No. 7 – May 12, 2025
Economic, Tech changes drive lab concerns, The Dark Report provides insights from the Executive War College speakers about how clinical labs can use business strategies and tactics to handle the new tariffs, future regulations, and artificial intelligence (AI). Also, this issue provides guidance on how labs and pathologists should prepare for payer audits.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized